Omicron fears return as boss of vaccine maker Moderna spooks markets               

Moderna's chief executive Stéphane Bancel told the Financial Times: "All the scientists I've talked to ... are like: 'This is not going to be good'."

A pharmacist holding a vial of the Moderna Covid-19 vaccine. Picture: Yui Mok/PA Wire

Covid fears came back to haunt investors as the boss of US vaccine maker Moderna spooked European stock markets about the efficacy of its vaccine against the Omicron variant. 

Global stock markets were also affected by the eurozone posting record-high inflation figures, which in turn put the spotlight on the ECB and its commitment to hold the line against hiking interest rates anytime soon.